A model should not be chosen solely because it produces the strongest predictive performance in the development dataset. Selection also considers calibration, interpretability, parsimony, and overfitting risk. A simpler or more understandable model may be preferable when its predictions remain sufficiently accurate and can be evaluated or used more transparently in clinical decision-making.
Calibration concerns whether a model’s predicted risks or outcomes correspond appropriately to what occurs in the relevant population. A model can appear useful based on overall predictive performance yet provide poorly aligned estimates for clinical decisions. Including calibration among selection criteria helps determine whether predictions can support reliable diagnosis, prognosis, treatment-response assessment, or patient-risk estimation.
Overfitting occurs when a model performs well on the development sample but does not maintain its accuracy beyond that sample. Selection methods address this risk by comparing candidate models through cross-validation and evaluation on independent data, rather than relying only on development results. This helps identify models more likely to generalize to other patient populations.
Cross-validation provides a structured way to compare candidate models using repeated divisions of the available data for development and evaluation. Its purpose is to examine whether performance is consistent rather than dependent on one development sample. In clinical research, this comparison can help reveal models that are less vulnerable to overfitting before considering their suitability for broader use.
Independent data are important when researchers need to assess whether a selected model remains reliable outside the sample used for development. Evaluation on such data provides evidence about performance in populations beyond the original dataset and complements cross-validation or information criteria. This step is especially relevant when predictions may guide real-world clinical decisions.
Researchers first relate candidate-model evaluation to the clinical question and intended use, then compare models using predictive performance, calibration, interpretability, parsimony, and overfitting risk. Cross-validation, information criteria, and independent-data evaluation support transparent comparisons. The resulting assessment helps determine which model is most suitable for estimating diagnosis, prognosis, treatment response, or patient risk.